Miranda, C.; Ruiz-Picazo, A.; Pomares, P.; Gonzalez-Alvarez, I.; Bermejo, M.; Gonzalez-Alvarez, M.; Avdeef, A.; Cabrera-Pérez, M.-Á.
Integration of In Silico, In Vitro and In Situ Tools for the Preformulation and Characterization of a Novel Cardio-Neuroprotective Compound during the Early Stages of Drug Development. Pharmaceutics 2022, 14, 182.
https://doi.org/10.3390/pharmaceutics14010182
AMA Style
Miranda C, Ruiz-Picazo A, Pomares P, Gonzalez-Alvarez I, Bermejo M, Gonzalez-Alvarez M, Avdeef A, Cabrera-Pérez M-Á.
Integration of In Silico, In Vitro and In Situ Tools for the Preformulation and Characterization of a Novel Cardio-Neuroprotective Compound during the Early Stages of Drug Development. Pharmaceutics. 2022; 14(1):182.
https://doi.org/10.3390/pharmaceutics14010182
Chicago/Turabian Style
Miranda, Claudia, Alejandro Ruiz-Picazo, Paula Pomares, Isabel Gonzalez-Alvarez, Marival Bermejo, Marta Gonzalez-Alvarez, Alex Avdeef, and Miguel-Ángel Cabrera-Pérez.
2022. "Integration of In Silico, In Vitro and In Situ Tools for the Preformulation and Characterization of a Novel Cardio-Neuroprotective Compound during the Early Stages of Drug Development" Pharmaceutics 14, no. 1: 182.
https://doi.org/10.3390/pharmaceutics14010182
APA Style
Miranda, C., Ruiz-Picazo, A., Pomares, P., Gonzalez-Alvarez, I., Bermejo, M., Gonzalez-Alvarez, M., Avdeef, A., & Cabrera-Pérez, M.-Á.
(2022). Integration of In Silico, In Vitro and In Situ Tools for the Preformulation and Characterization of a Novel Cardio-Neuroprotective Compound during the Early Stages of Drug Development. Pharmaceutics, 14(1), 182.
https://doi.org/10.3390/pharmaceutics14010182
